Population pharmacokinetics and pharmacodynamics of pegylated-liposomal doxorubicin in patients with AIDS-related Kaposi's sarcoma (Q40902814)

24 September 2017

title

Population pharmacokinetics and pharmacodynamics of pegylated-liposomal doxorubicin in patients with AIDS-related Kaposi's sarcoma (English)

1 reference

24 September 2017

0 references

1 reference

1 reference

1 reference

Amantea MA

1

1 reference

24 September 2017

Forrest A

series ordinal

2

1 reference

24 September 2017

Northfelt DW

series ordinal

3

1 reference

24 September 2017

Mamelok R

series ordinal

4

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 March 1997

1 reference

Clinical Pharmacology & Therapeutics

24 September 2017

number of pages

11

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

24 September 2017

volume

61

1 reference

24 September 2017

issue

3

1 reference

24 September 2017

page(s)

301-311

1 reference

Pharmacokinetic and imaging studies in patients receiving a formulation of liposome-associated adriamycin

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990162-4

Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990162-4

Development of a population pharmacokinetic model and optimal sampling strategies for intravenous ciprofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990162-4

Bilary disposition of adriamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990162-4

Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990162-4

Improved survival for patients with AIDS-related Kaposi's sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990162-4

Pulmonary Kaposi's sarcoma: clinical findings and results of therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990162-4

Prolongation of the circulation time of doxorubicin encapsulated in liposomes containing a polyethylene glycol-derivatized phospholipid: pharmacokinetic studies in rodents and dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990162-4

Chemoprevention and therapy of mouse mammary carcinomas with doxorubicin encapsulated in sterically stabilized liposomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990162-4

Alternative approaches to estimation of population pharmacokinetic parameters: comparison with the nonlinear mixed-effect model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990162-4

The population approach to pharmacokinetic data analysis: rationale and standard data analysis methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990162-4

A program package for simulation and parameter estimation in pharmacokinetic systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990162-4

A Bayesian extension of the minimum AIC procedure of autoregressive model fitting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990162-4

Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990162-4

Clinical pharmacokinetics of doxorubicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990162-4

Plasma and cellular adriamycin concentrations in patients with myeloma treated with ninety-six-hour continuous infusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990162-4

Vascularization of tumors: A review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990162-4

The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990162-4

10.1016/S0009-9236(97)90162-4

7 January 2021

Identifiers

DOI

1 reference

24 September 2017

1 reference